Recent Publications
Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MA, Shapiro NL, Nutescu EA. Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients. Pharmacotherapy. 2011;31(8):785-92.
Cavallari LH, Momary KM, Patel SR, Shapiro NL, Nutescu E, Viana M. Pharmacogenomics of warfarin dose requiremenrs in hispanics. Blood cells, Molecules & Diseases. 2011;46(2):147-50.
Cavallari LH, Perera M, Wadelius M, Deloukas P, Taube G, Patel SR, Aquino-Michaels K, Viana MA, Shapiro NL, Nutescu EA. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Pharmacogenetics and Genomics. 2011 Dec 12.
Barnum DT, Gleason JM, Karlaftis MG, Schumock GT, Shields KL, Tandon S, Walton SM. Estimating DEA confidence intervals with statistical panel data analysis. Journal of Applied Statistics. 2011 September 28; 38 (12): 1-14. (DOI:10.1080/02664763.2011.620948).
Barnum DT, Shields KL, Walton SM, Schumock GT. Improving the efficiency of distributive and clinical services in hospital pharmacy. Journal of Medical Systems. 2011 Jan; 35:59-70. (DIO 10.1007/s10916-009-9341-2).
Cella D, Pickard AS, Duh MS, Guerin A, Mishagina N, Antràs L, Neary MP, McCann L, Hodge R, Sternberg CN. Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial. European Journal of Cancer. 2011 Jun 18. [Epub ahead of print]
Chow SL, Singh H, DiDomenico RJ, Dunn SP, Johnson SG, Marrs JC, Vardeny O, Bleske BE. Key articles related to complementary and alternative medicine in cardiovascular disease: Part 2. Pharmacotherapy. 2011;31:208e-277e.
Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, Au DH. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BioMed Central Health Services Research. 2011; 11:37.
Doloresco F, Fominaya C, Schumock GT, Vermeulen LC, Matusiak L, Hunkler RJ, Shah ND, Hoffman JM. Projecting future drug expenditures – 2011. American Journal of Health-System Pharmacy. 2011 May 15;68(10):921-932. (DOI: 10.2146/ajhp100712).
Gulseth MP, Wittkowsky AK, Fanikos J, Spinler SA, Dager WE, Nutescu EA. Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness. Pharmacotherapy. 2011 Dec;31(12):1161-74.
Hughes SL, Seymour RB, Campbell RT, Shaw JW, Fabiyi C, Sokas R. Comparison of two health-promotion programs for older workers. American Journal of Public Health. 2011 May;101(5):883-90. Epub 2011 Mar 18.
Jolly M, Pickard AS, Mikolaitis RA, Cornejo J, Sequeira W, Cash TF, Block JA. Body Image in Patients with Systemic Lupus Erythematosus. International Journal of Behavioral Medicine. 2011 Mar 6. [Epub ahead of print] PubMed PMID: 21380770.
Jolly M, Pickard AS, Sequeira W, Wallace DJ, Solem CT, Mikolaitis RA, Fogg L, Weisman MH, Block JA, Cash TF. A Brief Assessment Tool for Body Image in Systemic Lupus Erythematosus. Body Image. 2011 Dec 7. [Epub ahead of print] PMID: 22154813.
Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. Journal of General Internal Medicine. 2011; 26(11): 1272-1277.
Lau DT, Briesacher BA, Touchette DR, Stubbings JA, and Ng JH. Medicare Part D and quality of prescription medication use in older adults. Drugs & Aging. 2011;28(10);797-807.
Lau DT, Mercaldo ND, Shega JW, Rademaker A, Weintraub S. Functional Decline Associated With Polypharmacy and Potentially Inappropriate Medications in Community-Dwelling Older Adults With Dementia. American Journal of Alzheimer's Disease and Other Dementias. 2011 Dec 28. [Epub ahead of print] PMID: 22207646
Lee JC, Hasnain-Wynia R, Lau DT. Delay in Seeing a Doctor Due to Cost: Disparity between Older Adults with and without Disabilities in the United States. Health Services Research. 2011 Nov 8. doi: 10.1111/j.1475-6773.2011.01346.x.
Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM. The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility. Health Services Research. 2011 Aug;46(4):1104-1123. Epub 2011 May 24. PubMed PMID: 21609328.
Martin MT, Nutescu EA. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery. Current Medical Research and Opinion. 2011;27(11):2123-31.
Martin MT, Spinler SA, Nutescu EA. Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel. Clinical Therapeutics. 2011;33(4):425-42.
Morden NE, Sullivan SD, Bartle B, Lee TA. Skeletal health in men with chronic lung disease: rates of testing, treatment and fractures. Osteoporosis International. 2011; 22(6): 1855-1862.
Murthy K, Grobman WA, Lee TA, Holl JL. Trends in induction of labor at early-term gestation. American Journal of Obstetrics and Gynecology. 2011; 204(5): 435.e1-36.
Murthy K, Holl JL, Lee TA, Grobman WA. National trends and racial differences in late preterm induction. American Journal of Obstetrics and Gynecology. 2011; 205(5): 458.e1-7.
Nordstrom BL, Kachroo S, Fraeman KH, Nutescu EA, Schein JR, Fisher A, Bookhart BK. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism. Current Medical Research and Opinion. 2011;27(10):1973-85.
Nutescu EA, Bathija S, Sharp LK, Gerber BS, Schumock GT, Fitzgibbon ML. Anticoagulation patient self-monitoring in the United States: Consideration for clinical practice adoption. Pharmacotherapy. 2011;31(12):1161-1174.
Nutescu E. Characteristics of novel anticoagulants and potential economic implications. American Journal of Managed Care. 2011;17(1 Suppl):S27-32.
Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. Journal of Thrombosis and Thrombolysis. 2011;31(3):326-43.
Overk CR, Lu PY, Wang YT, Choi J, Shaw JW, Thatcher GR, Mufson EJ. Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice. Neurobiology of Disease. 2012 Jan;45(1):479-87. Epub 2011 Sep 16.
Pickard AS, Lee TA, Solem CT, Joo MJ, Schumock GT, Krishnan JA. Prioritizing Comparative-Effectiveness Research Topics via Stakeholder Involvement: An Application in COPD. Clinical Pharmacology and Therapeutics. 2011 Dec;90(6):888-92. Epub 2011 Nov 2. PubMed PMID: 22048220.
Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Quality of Life Outcomes. 2011; 9(1): 26.
Perez A, Touchette DR, DiDomenico RJ. Walton SM. Cost and effectiveness analysis comparing rate versus rhythm control for atrial fibrillation management with co-existing heart failure. Pharmacotherapy. 2011; 31(6): 552-565.
Revicki DA, Margolis MK, Thompson CL, Meltzer EO, Sandor DW, Shaw JW. Major symptom score utility index for patients with acute rhinosinusitis. American Journal of Rhinology & Allergy. 2011 May-Jun;25(3):99-106.
Shapiro NL, Kominiarek MA, Nutescu EA, Chevalier AB, Hibbard JU. Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience. Pharmacotherapy. 2011;31(7):678-85.
Shaw JW. Use of patient versus population preferences in economic evaluations of health care interventions. Clinical Therapeutics. 2011 Jul;33(7):898-900. Epub 2011 Jun 29.
Scheetz MH, Bolon MK, Esterly JS, Reddy P, Postelnick M, Lee TA. Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. Pharmacotherapy. 2011; 31(5): 469-479.
Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Safety. 2011; 34(7): 533-544.
Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT. Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US. Drug, Healthcare and Patient Safety. 2011; 3: 47-57.
Schumock GT, Walton SM, Lee TA, Marx SE, Audhya P, Andress DL. Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. Nephron Clinical Practice. 2011; 117(2): c151-c159.
Sohn MW, Budiman-Mak E, Lee TA, Oh E, Stuck RM. Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes Metabolism, Research and Reviews. 2011; 27(4): 402-409.
Stein BD, Bautista A,Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA.The validity of ICD-9-COM diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2011 July 14; (DOI: 10.1378/chest.11-0024).
Stubbings JA, Nutescu E, Durley SF, and Bauman JL. Payment for clinical pharmacy services revisited. Pharmacotherapy. 2011;31(1):1-8.
Tiryaki F, Nutescu EA, Hennenfent JA, Karageanes AM, Koesterer LJ, Lambert BL, Schumock GT. Anticoagulation therpy for hospitalized patients: patterns of use, compliance with national guidelines, and performance on quality measures. American Journal of Health-System Pharmacy. 2011 July 1;68:1239-44. (DOI: 10.2146/ajhp100543).
Vekeman F, LaMori JC, Laliberte F, Nutescu E, Duh MS, Bookhart BK, et al. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population. Journal of Medical Economics. 2011;14:324-34.
Walton SM, Galanter WL, Rosencranz H, Meltzer D, Stafford RS, Tiryaki F, Sarne D. A trial of inpatient indication based prescribing during computerized order entry with medications commonly used off-label. Applied Clinical Informatics. 2011; 2: 94–103.
Yu S, Galanter WL, DiDomenico RJ, Borkowsky S, Schiff GD, Lambert BL. Consensus list of priority drug-lab linkages for an inpatient asynchronous alert program: results of a Delphi survey. American Journal of Health-System Pharmacy. 2011;68:407-14.